Literature DB >> 3768533

Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells.

D K Kaul, M E Fabry, R L Nagel.   

Abstract

We have characterized the type of red cells from sickle cell patients that were trapped in the course of sickle-cell vaso-occlusion. In addition, the perfusion conditions (arterial perfusion pressure [Pa] and oxygen tension [PO2]) leading to experimentally induced vaso-occlusion in the artificially perfused, innervated mesocecum microvascular preparation were determined. Microvascular obstruction was induced by decrease in Pa; the lower the Pa, the greater the peripheral resistance as well as the extent of obstruction. The cells involved in the obstruction were recovered by vasodilation (secondary to denervation) and increase in Pa. Densitometric analysis of density gradient-separated infused and trapped cells was supplemented with morphological analysis to ascertain the involvement of density classes as well as morphological types seen in oxy and deoxy sickle blood. The trapping phenomenon was sensitive to PO2. Percentage of densest gradient classes, ie, fraction 3 (F3; mainly dense unsicklable SS discocytes [USDs]) and fraction 4 (F4; irreversibly sickled cells [ISCs] and the densest discocytes), showed a significant increase in trapping when perfusion was switched from oxy to deoxy perfusate. Morphological analysis revealed that unsicklable SS discocytes are more effectively trapped when deoxygenated. The deoxygenation of infused cells did not further change the percentage of ISCs trapped, suggesting that ISCs are equally capable of sequestration in the oxy and the deoxy states. The venous effluent showed a selective and significant depletion of dense cells (F4) and ISC counts at all Pa. We conclude that the progressive obstruction of the microcirculation by sickle cells involves selective sequestration of the densest classes of cells and that this mechanism might explain their partial disappearance during painful sickle cell crisis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768533

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  The effect of fetal hemoglobin on the survival characteristics of sickle cells.

Authors:  Robert S Franco; Zahida Yasin; Mary B Palascak; Peter Ciraolo; Clinton H Joiner; Donald L Rucknagel
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

2.  Flickering analysis of erythrocyte mechanical properties: dependence on oxygenation level, cell shape, and hydration level.

Authors:  Young-Zoon Yoon; Ha Hong; Aidan Brown; Dong Chung Kim; Dae Joon Kang; Virgilio L Lew; Pietro Cicuta
Journal:  Biophys J       Date:  2009-09-16       Impact factor: 4.033

3.  Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications.

Authors:  D K Kaul; M E Fabry; R L Nagel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Steady state hemoglobin concentration and packed cell volume in homozygous sickle cell disease patients in Lagos, Nigeria.

Authors:  Akinsegun Akinbami; Adedoyin Dosunmu; Adewumi Adediran; Olajumoke Oshinaike; Adebola Phillip; Osunkalu Vincent; Arogundade Olanrewaju; Adelekan Oluwaseun
Journal:  Caspian J Intern Med       Date:  2012

Review 5.  Biomechanics and biorheology of red blood cells in sickle cell anemia.

Authors:  Xuejin Li; Ming Dao; George Lykotrafitis; George Em Karniadakis
Journal:  J Biomech       Date:  2016-11-12       Impact factor: 2.712

Review 6.  Sickle cell vasoocclusion: many issues and some answers.

Authors:  D K Kaul; R L Nagel
Journal:  Experientia       Date:  1993-01-15

7.  Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes.

Authors:  Tennille D Presley; Andreas S Perlegas; Lauren E Bain; Samir K Ballas; James S Nichols; Hernan Sabio; Mark T Gladwin; Gregory J Kato; Daniel B Kim-Shapiro
Journal:  Hemoglobin       Date:  2010       Impact factor: 0.849

8.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

9.  Sickle cell disease in central India.

Authors:  Archana B Patel; Ambarish M Athavale
Journal:  Indian J Pediatr       Date:  2004-09       Impact factor: 1.967

10.  Modeling sickle cell vasoocclusion in the rat leg: quantification of trapped sickle cells and correlation with 31P metabolic and 1H magnetic resonance imaging changes.

Authors:  M E Fabry; V Rajanayagam; E Fine; S Holland; J C Gore; R L Nagel; D K Kaul
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.